iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs

Mesenchymal stromal cells derived from induced pluripotent stem cells (iMSCs) have been proposed as alternative sources of primary MSCs with various advantages for cell therapeutic trials. However, precise evaluation of the differences between iMSCs and primary MSCs is lacking due to individual vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hae-Ri, Kim, Soo, Shin, Sungho, Jeong, Seon-Yeong, Lee, Dae-Won, Lim, Sun-Ung, Kang, Ji Yeon, Son, Mi-Young, Lee, Cheolju, Yu, Kyung-Rok, Kim, Myungshin, Oh, Il-Hoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821152/
https://www.ncbi.nlm.nih.gov/pubmed/36614321
http://dx.doi.org/10.3390/ijms24010881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821152/
https://www.ncbi.nlm.nih.gov/pubmed/36614321
http://dx.doi.org/10.3390/ijms24010881

Ejemplares similares